imiquimod has been researched along with acetyl-11-ketoboswellic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di, TT; Li, P; Lin, Y; Meng, YJ; Wang, MX; Wang, N; Wang, Y; Xie, XJ; Xu, XL; Zhang, L; Zhao, JX | 1 |
| Bai, J; Cai, W; Chen, L; Gao, Y; Li, Q; Lou, F; Lu, S; Niu, L; Sun, Y; Wang, H; Wang, Z; Wei, Z; Xu, Z; Yin, Q; Zhang, J; Zhou, A; Zhou, H | 1 |
2 other study(ies) available for imiquimod and acetyl-11-ketoboswellic acid
| Article | Year |
|---|---|
Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
Topics: Aminoquinolines; Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Proliferation; Coculture Techniques; Cytokines; Dendritic Cells; Erythema; Imiquimod; Inflammation; Interleukin-12 Subunit p35; Interleukin-23 Subunit p19; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Psoriasis; RNA, Messenger; Signal Transduction; Spleen; Toll-Like Receptor 7; Toll-Like Receptor 8; Triterpenes | 2018 |
Identification of a natural inhibitor of methionine adenosyltransferase 2A regulating one-carbon metabolism in keratinocytes.
Topics: Administration, Topical; Allosteric Site; Animals; Carbon; Cell Line; Down-Regulation; Humans; Imiquimod; Keratinocytes; Male; Metabolomics; Methionine Adenosyltransferase; Mice; Models, Molecular; Molecular Docking Simulation; Protein Conformation; Psoriasis; Triterpenes | 2019 |